Boston Scientific (BSX): UniSuper Management Pty Ltd reduced its stake -68K shares
UniSuper Management Pty Ltd reduced its stake in Boston Scientific, per its Q2 2025 13F.
- 910K
- Shares reported · -68K vs prior quarter
- 0.66%
- Disclosed portfolio weight
- $97.8M
- Reported value
- Holdings as of
- Jun 30, 2025
- Filed
- Jul 22, 2025
What stands out in this filing
- 978,091 shares in Q1 2025, 910,161 now (−6.9% in share count).
- Reported at $97.8M, 0.66% of the portfolio value in this 13F filing.
- 74 other tracked managers reported the same kind of change for Q2 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 29, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- Dec 11, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
- May 12, 2025CongressDisclosed sale of BSX — reported range $15,001 - $50,000
- May 13, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- May 29, 2025InsiderDirector sold ~$418K of BSX shares in the open market
- Jun 2, 2025Insider · 1 personInsiders: 2 sales (~$17.1M)
- Jun 4, 2025InsiderOfficer sold ~$5.8M of BSX shares in the open market
- Jun 11, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Jun 26, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Jul 1, 2025InsiderOfficer sold ~$5.35M of BSX shares in the open market
What came next
- Jul 25, 2025InsiderDirector sold ~$424K of BSX shares in the open market
- Jul 29, 2025InsiderDirector sold ~$310K of BSX shares in the open market
- Jul 31, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Aug 1, 2025Insider · 2 peopleInsiders: 2 sales (~$7.0M)
- Aug 4, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
- Aug 28, 2025FDARecall: Extractor Pro RX Retrieval Balloon Catheter; UPN (REF): (1) M00547030 (9-12mm Below), (2) M00547000 (9-12mm Above);
- Sep 2, 2025Insider · 1 personInsiders: 2 sales (~$5.3M)
- Sep 11, 2025FDARecall: TENACIO Pump without InhibiZone; UPN: 72404420;
- Sep 11, 2025FDARecall: TENACIO Pump with InhibiZone; UPN: 72404429;
- Sep 11, 2025FDARecall: LGX Preconnect with TENACIO Pump without InhibiZone; UPNs: (1) 72404405 (12CM IP), (2) 72404407 (18CM IP);
- Sep 11, 2025FDARecall: CXR Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404461 (12CM PS IZ), (2) 72404462 (14CM PS IZ), (3) 72404463 (16CM PS IZ), (4) 72404464 (18C…
- Sep 11, 2025FDARecall: CX Preconnect with TENACIO Pump without InhibiZone; UPNs: (1) 72404486 (15CM IP), (2) 72404488 (21CM IP);
- Sep 11, 2025FDARecall: LGX Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404450 (12CM PS IZ), (2) 72404451 (15CM PS IZ), (3) 72404452 (18CM PS IZ), (4) 72404453 (21C…
- Sep 11, 2025FDARecall: CX Preconnect with TENACIO Pump with InhibiZone; UPNs: (1) UPN: 72404430 (12CM PS IZ), (2) 72404431 (15CM PS IZ), (3) 72404432 (18CM PS IZ), (4) 72404433 (21CM…
- Sep 12, 2025FDAFDA device clearance: LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312)
- Sep 23, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
- Sep 24, 2025FDAFDA device clearance: LithoVue Elite Single-Use Digital Flexible Ureteroscope - Standard with pressure monitoring (M0067940000); LithoVue Elite Single-Use Digital Flexible Ureterosc…
- Sep 26, 2025FDAFDA device clearance: Radial Jaw 4 Pulmonary Biopsy Forceps
- Oct 9, 2025FDAFDA device clearance: Orca Air/Water and Suction Valves
- Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
How this filing works
Explore the data
Common questions
What does this filing report about Boston Scientific (BSX) stock?
UniSuper Management Pty Ltd reduced its stake in Boston Scientific, per its Q2 2025 13F. Now 910K shares, $97.8M reported value, 0.66% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Jun 30, 2025. Filed: Jul 22, 2025.
What stands out in this filing?
978,091 shares in Q1 2025, 910,161 now (−6.9% in share count). Reported at $97.8M, 0.66% of the portfolio value in this 13F filing. 74 other tracked managers reported the same kind of change for Q2 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Boston Scientific recently?
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.
Does this mean BSX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Boston Scientific
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
